Raymond James Financial’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Sell
96,108
-8,781
-8% -$22K ﹤0.01% 5036
2026
Q1
$223K Buy
104,889
+1,033
+1% +$2K ﹤0.01% 4833
2025
Q4
$159K Buy
103,856
+2,600
+3% +$4.32K ﹤0.01% 4842
2025
Q3
$149K Buy
101,256
+34,215
+51% +$50.8K ﹤0.01% 4684
2025
Q2
$119K Hold
67,041
– – ﹤0.01% 4784
2025
Q1
$97.9K Hold
67,041
– – ﹤0.01% 4549
2024
Q4
$103K Buy
+67,041
New +$109K ﹤0.01% 4523

Other funds holding CGEN

Raymond James Financial's CGEN Position: Q2 2026 in Review

Raymond James Financial reduced its Compugen (CGEN) stake by 8.4% in Q2 2026, selling an estimated $22K and leaving 96,108 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #5036.

Raymond James Financial first reported a position in CGEN in Q4 2024 and has held it in 7 quarters since. The position peaked at $223K in Q1 2026. 83 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

  • Raymond James Financial held 96,108 shares of Compugen worth $206K as of Q2 2026.
  • Raymond James Financial sold 8,781 Compugen shares in Q2 2026, an estimated $22K.
  • Compugen made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5036 holding.
  • Raymond James Financial first reported a position in Compugen in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Compugen position peaked at $223K in Q1 2026.
  • 83 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.